Trials / Withdrawn
WithdrawnNCT01052363
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- West Virginia University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot Trial of CA4P with Avastin in Recurrent Gliomas
Detailed description
The purpose of this study is to see if fosbretabulin, the drug being studied, combined with bevacizumab will help your brain cancer and if using these drugs together is safe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab, CA4P |
Timeline
- Start date
- 2010-01-01
- First posted
- 2010-01-20
- Last updated
- 2017-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01052363. Inclusion in this directory is not an endorsement.